The changing landscape of molecular diagnostic testing: Implications for academic medical centers

Journal of Personalized Medicine

Volumn 6, Issue 1, 2016, Pages

  Rehm, Heidi L ^a,b   Hynes, Elizabeth ^a   Funke, Birgit H ^a,c  

^a LABORATORY FOR MOLECULAR MEDICINE   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Academic medical centers; Biobank; Clinical translational research; Commercial academic partnerships; Comprehensive testing; Laboratory of Molecular Medicine; Laboratory physician collaborations; Molecular diagnostics; Next generation sequencing; Partners HealthCare

Indexed keywords

ARTICLE; BIOINFORMATICS; FOOD AND DRUG ADMINISTRATION; GENOTYPING TECHNIQUE; HIGH THROUGHPUT SEQUENCING; MOLECULAR DIAGNOSIS; MOLECULAR MEDICINE; NEXT GENERATION SEQUENCING; STAFF TRAINING; TOTAL QUALITY MANAGEMENT; TRANSLATIONAL RESEARCH; UNIVERSITY HOSPITAL;

EID: 85016035362     PISSN: None     EISSN: 20754426     Source Type: Journal    
DOI: 10.3390/jpm6010008     Document Type: Article

References (18)

1. Xue, Y.; Ankala, A.; Wilcox, W.R.; Hegde, M.R. Solving the molecular diagnostic testing conundrum for Mendelian disorders in the era of next-generation sequencing: Single-gene, gene panel, or exome/genome sequencing. Genet. Med. 2015, 17, 444-451. [CrossRef] [PubMed].
2. Sawyer, S.L.; Hartley, T.; Dyment, D.A.; Beaulieu, C.L.; Schwartzentruber, J.; Smith, A.; Bedford, H.M.; Bernard, G.; Bernier, F.P.; Brais, B.; et al. Utility of whole-exome sequencing for those near the end of the diagnostic odyssey: Time to address gaps in care. Clin. Genet. 2015. [CrossRef] [PubMed].
3. Richards, J.; Korgenski, E.K.; Srivastava, R.; Bonkowsky, J.L. Costs of the diagnostic odyssey in children with inherited leukodystrophies. Neurology 2015, 85, 1167-1170. [CrossRef] [PubMed].
4. Neveling, K.; Feenstra, I.; Gilissen, C.; Hoefsloot, L.H.; Kamsteeg, E.J.; Mensenkamp, A.R.; Rodenburg, R.J.; Yntema, H.G.; Spruijt, L.; Vermeer, S.; et al. A post-hoc comparison of the utility of Sanger sequencing and exome sequencing for the diagnosis of heterogeneous diseases. Hum. Mutat. 2013, 34, 1721-1726. [CrossRef] [PubMed].
5. Pugh, T.; Amr, S.; Bowser, M.; Gowrisankar, S.; Hynes, E.; Mahanta, L.; Rehm, H.; Funke, B.; Lebo, M. VisCap: Inference and visualization of germline copy number variants from targeted clinical sequencing data. Genet. Med. 2015. [CrossRef] [PubMed].
6. Retterer, K.; Scuffins, J.; Schmidt, D.; Lewis, R.; Pineda-Alvarez, D.; Stafford, A.; Schmidt, L.; Warren, S.; Gibellini, F.; Kondakova, A.; et al. Assessing copy number from exome sequencing and exome array CGH based on CNV spectrum in a large clinical cohort. Genet. Med. 2015, 17, 623-629. [CrossRef] [PubMed].
7. Feng, Y.; Chen, D.;Wang, G.L.; Zhang, V.W.;Wong, L.J. Improved molecular diagnosis by the detection of exonic deletions with target gene capture and deep sequencing. Genet. Med. 2015, 17, 99-107. [CrossRef] [PubMed].
8. Tattini, L.; D'Aurizio, R.; Magi, A. Detection of genomic structural variants from next-generation sequencing data. Front Bioeng. Biotechnol. 2015, 3, 92. [CrossRef] [PubMed].
9. Gowrisankar, S.; Lerner-Ellis, J.P.; Cox, S.; White, E.T.; Manion, M.; LeVan, K.; Liu, J.; Farwell, L.M.; Iartchouk, O.; Rehm, H.L.; et al. Evaluation of second-generation sequencing of 19 dilated cardiomyopathy genes for clinical applications. J. Mol. Diagn. 2010, 12, 818-827. [CrossRef] [PubMed].
10. Gargis, A.S.; Kalman, L.; Berry, M.W.; Bick, D.P.; Dimmock, D.P.; Hambuch, T.; Lu, F.; Lyon, E.; Voelkerding, K.V.; Zehnbauer, B.A.; et al. Assuring the quality of next-generation sequencing in clinical laboratory practice. Nat. Biotechnol. 2012, 30, 1033-1036. [CrossRef] [PubMed].
11. Rehm, H.L. Disease-targeted sequencing: A cornerstone in the clinic. Nat. Rev. Genet. 2013, 14, 295-300. [CrossRef] [PubMed].
12. Rehm, H.L.; Bale, S.J.; Bayrak-Toydemir, P.; Berg, J.S.; Brown, K.K.; Deignan, J.L.; Friez, M.J.; Funke, B.H.; Hegde, M.R.; Lyon, E.; et al. ACMG clinical laboratory standards for next-generation sequencing. Genet. Med. 2013, 15, 733-747. [CrossRef].
13. Zimmerman, R.S.; Cox, S.; Lakdawala, N.K.; Cirino, A.; Mancini-DiNardo, D.; Clark, E.; Leon, A.; Duffy, E.; White, E.; Baxter, S.; et al. A novel custom resequencing array for dilated cardiomyopathy. Genet. Med. 2010, 12, 268-278. [CrossRef] [PubMed].
14. Waldmüller, S.; Müller, M.; Rackebrandt, K.; Binner, P.; Poths, S.; Bonin, M.; Scheffold, T. Array-based resequencing assay for mutations causing hypertrophic cardiomyopathy. Clin. Chem. 2008, 54, 682-687. [CrossRef] [PubMed].
15. Teekakirikul, P.; Cox, S.; Funke, B.; Rehm, H.L. Targeted sequencing using Affymetrix CustomSeq Arrays. Curr. Protoc. Hum. Genet. 2011. [CrossRef].
16. Aronson, S.J.; Clark, E.H.; Babb, L.J.; Baxter, S.; Farwell, L.M.; Funke, B.H.; Hernandez, A.L.; Joshi, V.A.; Lyon, E.; Parthum, A.R.; et al. The GeneInsight Suite: A platform to support laboratory and provider use of DNA-based genetic testing. Hum. Mutat. 2011, 32, 532-536. [CrossRef] [PubMed].
17. Vassy, J.L.; Lautenbach, D.M.; McLaughlin, H.M.; Kong, S.W.; Christensen, K.D.; Krier, J.; Kohane, I.S.; Feuerman, L.Z.; Blumenthal-Barby, J.; Roberts, J.S.; et al. The MedSeq Project: A randomized trial of integrating whole genome sequencing into clinical medicine. Trials 2014, 15, 85. [CrossRef] [PubMed].
18. Rehm, H.L.; Berg, J.S.; Brooks, L.D.; Bustamante, C.D.; Evans, J.P.; Landrum, M.J.; Ledbetter, D.H.; Maglott, D.R.; Martin, C.L.; Nussbaum, R.L.; et al. ClinGen-The clinical genome resource. N. Engl. J. Med. 2015, 372, 2235-2242. [CrossRef] [PubMed].